Section: Pet Bacteria

Leptospirosis in Dogs: Bacteriology, Pathogenesis, Clinical Diagnostics, and Molecular Epidemiology

Introduction

Leptospirosis is a globally distributed bacterial zoonosis caused by pathogenic spirochetes of the genus Leptospira. In domestic dogs, the disease represents a significant cause of acute kidney injury, hepatic dysfunction, and pulmonary hemorrhage. The clinical severity ranges from subclinical infection to fulminant multi-organ failure. This article provides a detailed veterinary reference on the bacteriological characteristics, pathophysiological mechanisms, diagnostic approaches, and epidemiological patterns of canine leptospirosis, with emphasis on molecular detection and serological interpretation.

Bacteriology and Taxonomic Classification

The genus Leptospira belongs to the phylum Spirochaetes, order Spirochaetales, and family Leptospiraceae. These bacteria are obligate aerobes characterized by a helical morphology, with a cell body approximately 0.1 micrometers in diameter and 6 to 20 micrometers in length. The protoplasmic cylinder is wrapped by a periplasmic flagellum (endoflagellum) that confers the characteristic corkscrew motility essential for tissue penetration.

Pathogenic species are classified within the L. interrogans sensu lato group, which includes L. interrogans, L. kirschneri, L. borgpetersenii, L. noguchii, L. weilii, and L. santarosai. More than 300 serovars have been described, with serovar classification based on lipopolysaccharide (LPS) antigenic determinants. In dogs, the most frequently identified serovars include Canicola, Icterohaemorrhagiae, Grippotyphosa, Pomona, and Australis. Genomic comparison of Leptospira interrogans isolates from dogs, humans, and wildlife has revealed substantial genetic diversity and host adaptation patterns, with specific clonal lineages associated with canine clinical cases [10].

Pathogenesis and Host-Pathogen Interactions

Route of Infection and Dissemination

Infection occurs through direct contact with urine from infected reservoir hosts or through contaminated water, soil, or fomites. The spirochetes penetrate mucous membranes or abraded skin. Following entry, the bacteria rapidly enter the bloodstream, establishing a leptospiremic phase that lasts approximately 4 to 12 days. During this phase, organisms disseminate to multiple organs, including the kidneys, liver, lungs, eyes, and central nervous system.

Molecular Mechanisms of Tissue Tropism

The outer membrane of pathogenic Leptospira contains a suite of adhesins, including LigA, LigB, and Loa22, which mediate attachment to host extracellular matrix components such as fibronectin, laminin, and collagen. Loa22 is a surface-exposed lipoprotein that has been demonstrated to be essential for virulence in animal models. The recombinant Loa22 protein has been utilized in the development of serodiagnostic assays, including gold nanoparticle-based lateral flow platforms for detection of anti-leptospiral antibodies in canine serum [12].

The bacteria evade the host complement system through recruitment of factor H and C4b-binding protein, and they resist phagocytosis through their helical motility and LPS structure. The inflammatory response triggered by leptospiral LPS and lipoproteins leads to endothelial activation, increased vascular permeability, and tissue hemorrhage.

Renal Pathophysiology

The kidney is a primary target organ. Leptospires adhere to proximal renal tubular epithelial cells via interactions between bacterial adhesins and megalin/cubilin receptors. The organisms multiply within the tubular lumen and interstitium, causing tubular necrosis, interstitial nephritis, and peritubular vasculitis. The resulting acute kidney injury is characterized by azotemia, isosthenuria, and proteinuria. Chronic colonization of the renal tubules can persist for months to years, with intermittent shedding of viable organisms in urine.

Hepatic and Pulmonary Involvement

Hepatic involvement manifests as hepatocellular dissociation, canalicular cholestasis, and bilirubinostasis. The hallmark histopathological finding is disorganization of hepatic cords with widening of the sinusoidal spaces. Pulmonary leptospirosis, or leptospiral pulmonary hemorrhage syndrome, results from endothelial damage and increased vascular permeability leading to intra-alveolar hemorrhage. Serial evaluation of clinical, functional, and structural pulmonary changes in dogs with leptospirosis has demonstrated that pulmonary abnormalities can be detected through advanced imaging and bronchoalveolar lavage analysis, even in the absence of overt respiratory signs [1].

Clinical Presentation

The clinical spectrum of canine leptospirosis is broad and depends on the infecting serovar, the infectious dose, the host immune status, and the presence of concurrent disease. The incubation period ranges from 5 to 14 days.

Acute and Subacute Forms

The acute form is characterized by sudden onset of fever (39.5 to 41.0 degrees Celsius), lethargy, anorexia, vomiting, and abdominal pain. Polydipsia and polyuria may be present due to renal tubular dysfunction. Icterus is a common finding in infections caused by serovars Icterohaemorrhagiae and Grippotyphosa. Subacute cases present with more insidious signs, including weight loss, intermittent fever, and mild azotemia.

Pulmonary Hemorrhage Syndrome

A subset of dogs develops severe pulmonary involvement with dyspnea, tachypnea, hemoptysis, and hypoxemia. Thoracic radiography reveals diffuse alveolar and interstitial patterns. This syndrome carries a guarded to poor prognosis and requires intensive respiratory support.

Ocular and Neurologic Manifestations

Uveitis, conjunctivitis, and episcleral injection have been reported. Neurologic signs, including ataxia, seizures, and cervical hyperesthesia, are less common but can occur due to leptospiral meningitis or vasculitis.

Diagnostic Approaches

Serological Testing

The microscopic agglutination test (MAT) remains the reference standard for serological diagnosis. The MAT detects agglutinating antibodies (primarily IgM and IgG) against a panel of live leptospiral serovars. A single titer of 1:800 or greater in a dog with compatible clinical signs is considered supportive of active infection. A four-fold rise in titer between paired acute and convalescent sera (collected 2 to 4 weeks apart) confirms recent infection.

Seroprevalence studies have documented high rates of exposure in various geographic regions. In the Yangtze River region of China, seroprevalence rates exceeding 30% have been reported, with serovars Australis and Autumnalis being predominant [13]. In subtropical Mexico, seroprevalence in domiciled and stray dogs has been found to range from 15% to 40%, with higher rates in stray populations [15]. A systematic review and meta-analysis of canine leptospirosis in China identified multiple risk factors, including age, sex, and environmental exposure [6].

Molecular Detection

Polymerase chain reaction (PCR) assays targeting conserved genes such as secY, lipL32, flaB, and 16S rRNA are widely used for direct detection of leptospiral DNA in blood, urine, and tissue samples. Real-time PCR offers quantitative assessment and higher sensitivity compared to conventional PCR. Molecular surveillance studies have demonstrated the utility of PCR for identifying active infections in dogs, particularly during the leptospiremic phase when serology may be negative [11].

An outbreak investigation in Los Angeles County, California, utilized both PCR and MAT to characterize an outbreak of leptospirosis in dogs, revealing that serovar Pomona was the predominant causative serovar and that cases clustered in urban areas with high rodent populations [3].

Biomarker Assessment

Serum sialic acid has been investigated as a biomarker of inflammation and infection in veterinary medicine. Elevated total sialic acid levels have been observed in dogs with leptospirosis, correlating with disease severity and acute phase response [4]. Other biomarkers, including C-reactive protein, haptoglobin, and serum amyloid A, are elevated but lack specificity for leptospirosis.

Point-of-Care Assays

Lateral flow assays based on recombinant antigens such as Loa22 conjugated to gold nanoparticles have been developed for rapid serodiagnosis of leptospirosis in dogs. These assays provide results within 15 to 30 minutes and have demonstrated good sensitivity and specificity compared to MAT [12].

Diagnostic Decision Framework

The following Mermaid diagram illustrates a diagnostic workflow for canine leptospirosis.

flowchart TD
    A[Clinical Suspicion: Fever, Lethargy, Azotemia, Icterus], > B{Acute Phase < 7 days}
    B, >|Yes| C[Collect Blood for PCR and MAT]
    B, >|No| D[Collect Blood and Urine for PCR and MAT]
    C, > E{PCR Result}
    E, >|Positive| F[Confirm Active Infection]
    E, >|Negative| G[Collect Convalescent Serum in 2-4 weeks]
    D, > H{MAT Titer >= 1:800}
    H, >|Yes| I[Supportive of Recent Infection]
    H, >|No| J{Four-fold Rise on Paired Sera}
    J, >|Yes| K[Confirm Seroconversion]
    J, >|No| L[Consider Alternative Diagnosis]
    F, > M[Initiate Antimicrobial Therapy]
    I, > M
    K, > M

Treatment and Antimicrobial Susceptibility

The mainstay of therapy is antimicrobial administration combined with supportive care. Doxycycline (5 mg/kg orally every 12 hours or 10 mg/kg orally every 24 hours) is the drug of choice for eliminating the leptospiremic phase and clearing renal carriage. For dogs unable to tolerate oral medications, intravenous ampicillin (20 mg/kg every 6 to 8 hours) or penicillin G (25,000 to 40,000 U/kg every 12 hours) can be used initially, followed by a course of doxycycline.

Supportive care includes intravenous fluid therapy to correct dehydration and electrolyte imbalances, antiemetics, hepatoprotectants, and, in severe cases, hemodialysis or continuous renal replacement therapy. Dogs with pulmonary hemorrhage syndrome may require oxygen supplementation, mechanical ventilation, and blood product transfusion.

Epidemiology and Risk Factors

Geographic Distribution

Canine leptospirosis has a worldwide distribution, with higher incidence in tropical and subtropical regions where environmental conditions favor leptospiral survival in water and soil. In temperate regions, cases peak during late summer and autumn, correlating with increased rainfall and flooding events.

Reservoir Hosts and Transmission Dynamics

Wildlife species, including rodents, raccoons, opossums, and skunks, serve as maintenance hosts for various leptospiral serovars. Dogs become infected through direct or indirect contact with urine from these reservoir hosts. The risk of infection in dogs that have contact with clinical canine leptospirosis cases is significantly elevated, highlighting the importance of biosecurity measures in multi-dog households and kennels [8].

One Health Perspectives

Leptospirosis exemplifies the One Health concept, as the disease affects humans, domestic animals, and wildlife. Epidemiological studies in rural areas have demonstrated leptospiral interaction across bovine, canine, and human populations, with shared serovars and environmental contamination playing key roles in transmission [5]. Serological investigations in indigenous communities have revealed high seroprevalence in dogs, indicating that canine populations can serve as sentinels for human exposure risk [7].

Meteorological Influences

Meteorological factors, including temperature, precipitation, and humidity, significantly impact leptospirosis transmission dynamics. A scoping review of international evidence found that increased rainfall and flooding events are consistently associated with higher incidence of leptospirosis in domestic dog and cat populations [2].

Prevention and Vaccination

Vaccination is a cornerstone of leptospirosis prevention in dogs. Commercially available bacterin vaccines contain inactivated whole-cell preparations of the most prevalent serovars. Vaccination reduces the severity of clinical disease and decreases urinary shedding, although it does not provide sterile immunity and does not protect against all serovars. Annual revaccination is recommended for dogs at risk.

Public Health Considerations

Although this article focuses on canine disease, it is important to note that dogs can serve as a source of infection for humans through direct contact with urine or contaminated environments. Veterinary personnel and pet owners should practice appropriate hygiene measures, including glove use and disinfection of contaminated surfaces.

Future Directions

Advances in molecular diagnostics, including next-generation sequencing and metagenomic approaches, are improving the detection and characterization of leptospiral strains. Genomic comparison of isolates from different hosts and geographic regions is providing insights into the evolution and spread of pathogenic Leptospira [10]. The development of recombinant antigen-based serological assays and point-of-care devices is enhancing diagnostic accessibility in resource-limited settings.

References

  1. Bringold C, Schweighauser A, Walther S, et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42224492/

  2. Hobson SJ, Zai B, Vyn CM, et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211529/

  3. Randolph MW, Nally JE, Yoshimoto SK, et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42189535/

  4. Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42148179/

  5. Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC, et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42090421/

  6. Wei W, Jiao D, Dong X, et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta-analysis. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41864068/

  7. Galvão CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/

  8. Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41814781/

  9. Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W, et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41637464/

  10. Kakita T, Takabe K, Morita M, et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41579465/

  11. Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K, et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41557245/

  12. Gautam H, Kumar BVS, Singh S, et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41524783/

  13. Ding Y, Zhang S, Zhang W, et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41383393/

  14. Jost HE, Henriksen ML, Hawley J, et al. Evaluation of Leptospira species as a cause of endogenous uveitis in cats: a pilot study. J Feline Med Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41378760/

  15. Andrade-Silveira E, Segura-Correa JC, Ortega-Pacheco A, et al. Seroprevalence of pathogenic leptospira in domiciled and stray dogs from subtropical Mexico. Vet Res Commun. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41359150/